Shernan G Holtan - Division of Hematology, Oncology, and Transplantation, University of Minnesota

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Allogeneic Hematopoietic Cell Transplant for Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/telomere Biology Disorders: Single-center Single-Arm Open-Label Trial of Reduced Intensity Conditioning Without Radiation

Marketa Dimitrov,Svatava Merkle, Qing Cao,Rebecca K. Tryon,Gregory M. Vercellotti,Shernan G. Holtan,Roy L. Kao,Meera Srikanthan, Stephanie A. Terezakis,Jakub Tolar,Christen L. Ebens

TRANSPLANTATION AND CELLULAR THERAPYno. 10 (2024)

引用0浏览0WOS引用

FIGURE 3 from Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis

Armin Rashidi,Maryam Ebadi,Tauseef U. Rehman,Heba Elhusseini,David Kazadi,Hossam Halaweish,Mohammad H. Khan,Andrea Hoeschen,Qing Cao,Xianghua Luo,Amanda J. Kabage,Sharon Lopez,Sivapriya Ramamoorthy,Shernan G. Holtan,Daniel J. Weisdorf,Alexander Khoruts,Christopher Staley

crossref（2024）

引用0浏览0引用

FIGURE 5 from Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis

Armin Rashidi,Maryam Ebadi,Tauseef U. Rehman,Heba Elhusseini,David Kazadi,Hossam Halaweish,Mohammad H. Khan,Andrea Hoeschen, Qing Cao,Xianghua Luo,Amanda J. Kabage,Sharon Lopez,Sivapriya Ramamoorthy,Shernan G. Holtan,Daniel J. Weisdorf,Alexander Khoruts,Christopher Staley

crossref（2024）

引用0浏览0引用

Supplementary Table 6 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Joseph Pidala,Kelly Walton,Hany Elmariah,Jongphil Kim,Asmita Mishra,Nelli Bejanyan,Taiga Nishihori,Farhad Khimani,Lia Perez,Rawan G. Faramand, Marco L. Davila,Michael L. Nieder,Elizabeth M. Sagatys,Shernan G. Holtan, Nicholas J. Lawrence,Harshani R. Lawrence,Bruce R. Blazar,Claudio Anasetti,Said M. Sebti,Brian C. Betts

crossref（2023）

引用0浏览0引用

Supplementary Table 3 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Joseph Pidala,Kelly Walton,Hany Elmariah,Jongphil Kim,Asmita Mishra,Nelli Bejanyan,Taiga Nishihori,Farhad Khimani,Lia Perez,Rawan Faramand, Marco L. Davila,Michael L. Nieder,Elizabeth M. Sagatys,Shernan G. Holtan, Nicholas J. Lawrence,Harshani R. Lawrence,Bruce R. Blazar,Claudio Anasetti,Saı̈d M. Sebti,Brian C. Betts

openalex（2023）

引用0浏览0引用

Graft-versus-host Disease: Teaching Old Drugs New Tricks at Less Cost

Shatha Farhan,Shernan G Holtan

Frontiers in immunology (2023): 1225748-1225748

引用0浏览0WOS引用

Supplementary Table 1 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

openalex（2023）

引用0浏览0引用

Supplementary Table 7 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

crossref（2023）

引用0浏览0引用

Supplementary Table 2 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

crossref（2023）

引用0浏览0引用

Supplementary Figure S1 from Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality

Shernan G. Holtan,Constanza Savid-Frontera,Kelly Walton,Anne A. Eaton,Connor Demorest,Andrea Hoeschen,Ling Zhang,Kayla Reid,Tony Kurian,Zena Sayegh, Estefania Julia,Joseph Maakaron, Veronika Bachanova,Najla El Jurdi,Margaret L. MacMillan,Daniel J. Weisdorf,Martin Felices, Jeffrey S. Miller,Bruce R. Blazar, Marco L. Davila,Brian C. Betts

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn